# Transplanting Hepatitis C Lungs Into Negative Lung Recipients

> **NCT03724149** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Pennsylvania** · enrollment: 10 (actual)

## Conditions studied

- Lung Diseases

## Interventions

- **DRUG:** Zepatier
- **DRUG:** Epclusa

## Key facts

- **NCT ID:** NCT03724149
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-12
- **Primary completion:** 2021-12-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2023-04-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03724149

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03724149, "Transplanting Hepatitis C Lungs Into Negative Lung Recipients". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT03724149. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*